Monoethanolamine

Monoethanolamine

SCHEMBL2890477

CCCCCCCCN1CC(C(=O)O)CC1=O.NCCO

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
HTT P42858 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
GBA1 P04062 1/20 0.41
MAPT P10636 1/20 0.40
ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Monoethanolamine SCHEMBL2889305 0.93 L3MBTL1 (0.43) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL14477978 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL2890516 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL15082405 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL8084223 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL119623 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL8076306 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL8084202 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL14477954 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19
SCHEMBL1283867 0.92 POLB (0.56) POLBL3MBTL1SMN1; SMN2MEN1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349215-B2 Corrosion inhibitors having increased biological degradability and minimized toxicity CLARIANT FINANCE (BVI) LIMITED (VG) 2013-01-08 US disclosed
US-20100283010-A1 Corrosion Inhibitors Having Increased Biological Degradability And Minimized Toxicity CLARIANT FINANCE (BVI) LIMITED (VG) 2010-11-11 US disclosed